An ADC company is a specialized biopharmaceutical enterprise that researches, develops, and manufactures Antibody-Drug Conjugates. These advanced therapeutic molecules combine the precise tumor-targeting ability of monoclonal antibodies with the potent cell-killing power of cytotoxic chemical payloads via a chemical linker. This sophisticated design allows drugs to home in directly on cancer cells while sparing healthy surrounding tissue, representing a cutting-edge frontier in modern targeted oncology.